Canning
Since 1965 we have helped people like you to communicate more effectively while doing business across borders. The worldwide web is full of companies offering to do these things for you. What makes us different? Explore our website and have a look. Or, even better, contact us and talk to one of our team about what we could do for you and your organisation. Our existing clients know we are the best. You need to discover that for yourself.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
M3 (EU)
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
Inizio Ignite Sparks a New Era of Connected Advisory Solutions
Press Releases | January 7, 2026 | Inizio
Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.
MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke
White Papers and Resources | January 7, 2026 | Inizio
The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...
Uncovering Inequities in Alzheimer’s Disease Screening and Care
Press Releases | January 6, 2026 | Medscape Education
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...
Five Predictions That Will Reshape Biopharma Commercialisation in 2026
White Papers and Resources | January 5, 2026 | Nmblr
Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story. It’s a rough patch. A cycle that will reverse. But...
Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?
Press Releases | December 23, 2025 | Medscape Education
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
Does Rare Disease Education Work?
Press Releases | December 23, 2025 | Medscape Education
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.
From Genetic Puzzles to Precision Therapeutics
Press Releases | December 23, 2025 | Medscape Education
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...
Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series
Press Releases | December 23, 2025 | Medscape Education
Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...
What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?
Press Releases | December 23, 2025 | Medscape Education
Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...
Pharma’s digital dilemma: Finding the balance between speed, scale, and experience
Videos and Podcasts | December 19, 2025 | Graphite Digital
What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick...